4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-031188
Chief Commercial Officer sold 9,394 shares at $25.28 ($237,480)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Oliver Tracie · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-02 | Sale : show line 1 in the form 10b5-1 | −9,394 | $25.28 | $237,480 | 127,107 | D |
| Open-market sales · 9,394 sh · avg $25.28 · $237,480 | ||||||
Loading xslF345X05/wk-form4_1720042050.xml…